The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brooks, A. G.
Right arrow Articles by McCluskey, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brooks, A. G.
Right arrow Articles by McCluskey, J.

The Journal of Immunology, Vol 150, Issue 9 3690-3697, Copyright © 1993 by American Association of Immunologists


ARTICLES

Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells

AG Brooks and J McCluskey
Centre for Transfusion Medicine and Immunology, Flinders Medical Centre, Adelaide, South Australia.

A cDNA encoding a form of hen egg lysozyme (HEL) lacking a leader sequence and predicted to be localized in the cytoplasm, was transfected into MHC class II-positive B lymphoma cells. Cytoplasmically expressed HEL (cytHEL) had a half-life of less than 5 min and did not react with HEL specific mAb suggesting non-native conformation. Cells expressing cytoplasmic HEL, as well as cells previously reported to express a low level of HEL retained in the endoplasmic reticulum (ERHEL), constitutively presented the HEL determinant encoded by residues 46-61 to a sensitive class II- restricted T hybridoma (3A9). Constitutive presentation of HEL determinants was not detectable in cytHEL or ERHEL transfectants using T hybridomas with lower sensitivity to exogenous Ag. Constitutive presentation of HEL46-61 derived from cytoplasmic HEL was demonstrable in multiple transfected clones and was most obvious when a CMV rather than SV40 promoter was used to express the cytHEL gene. The presentation of HEL46-61 by cytHEL transfectants was not due to HEL reuptake by bystander cells because there was no biochemical evidence of cytHEL shedding and cytHEL supernatants added to indicator APC did not result in HEL46-61 presentation. Constitutive presentation of endogenous HEL46-61 by the cytHEL and ERHEL transfectants was inhibited by chloroquine, and recovery of presentation of endogenous HEL was slower in cytHEL compared with ERHEL transfectants. The findings indicate that class II-restricted presentation of Ag retained in the cytoplasm or endoplasmic reticulum does take place but probably requires abundant levels of intracellular Ag and is easily disrupted by lysosomotropic agents. These pathways of presentation may be important when high levels of foreign endoplasmic reticulum-retained or cytoplasmic Ag are present (e.g., viral infection), and during the acquisition of self-tolerance by highly sensitive developing T cells.


This article has been cited by other articles:


Home page
BloodHome page
B. E. Anderson, J. M. McNiff, D. Jain, B. R. Blazar, W. D. Shlomchik, and M. J. Shlomchik
Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ
Blood, March 1, 2005; 105(5): 2227 - 2234.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Dissanayake, N. Tuera, and S. Ostrand-Rosenberg
Presentation of Endogenously Synthesized MHC Class II-Restricted Epitopes by MHC Class II Cancer Vaccines Is Independent of Transporter Associated with Ag Processing and the Proteasome
J. Immunol., February 15, 2005; 174(4): 1811 - 1819.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Linnemann, G. Jung, and P. Walden
Detection and Quantification of CD4+ T Cells with Specificity for a New Major Histocompatibility Complex Class II-Restricted Influenza A Virus Matrix Protein Epitope in Peripheral Blood of Influenza Patients
J. Virol., September 15, 2000; 74(18): 8740 - 8743.
[Abstract] [Full Text]


Home page
JEMHome page
J. D. Lich, J. F. Elliott, and J. S. Blum
Cytoplasmic Processing Is a Prerequisite for Presentation of an Endogenous Antigen by Major Histocompatibility Complex Class II Proteins
J. Exp. Med., May 1, 2000; 191(9): 1513 - 1524.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. D. Baron, M. Foster-Cuevas, J. Baron, and T. Barrett
Expression in cattle of epitopes of a heterologous virus using a recombinant rinderpest virus
J. Gen. Virol., August 1, 1999; 80(8): 2031 - 2039.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
P. Bansal, P. Mukherjee, S. K. Basu, A. George, V. Bal, and S. Rath
MHC Class I-Restricted Presentation of Maleylated Protein Binding to Scavenger Receptors
J. Immunol., April 15, 1999; 162(8): 4430 - 4437.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. Gautam, R. Liblau, G. Chelvanayagam, L. Steinman, and T. Boston
A Viral Peptide with Limited Homology to a Self Peptide Can Induce Clinical Signs of Experimental Autoimmune Encephalomyelitis
J. Immunol., July 1, 1998; 161(1): 60 - 64.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Gueguen and E. O. Long
Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen
PNAS, December 10, 1996; 93(25): 14692 - 14697.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
H Bodmer, S Viville, C Benoist, and D Mathis
Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain
Science, March 4, 1994; 263(5151): 1284 - 1286.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.